In the world of cancer research, those who are experts on the subject of malignant mesothelioma are held in high regard, as the rare form of cancer has proven remarkably challenging to treat. That is why the gathering for the 8th International Symposium on Malignant Pleural Mesothelioma on September 29th at the Meyer & Renee Luskin Conference Center at UCLA will attract so much interest and attention. The event, which is jointly hosted by UCLA and the Pacific Mesothelioma Center, will provide global experts with the opportunity to share the most up-to-date information on the disease for clinicians, students and healthcare professionals of all kinds, as well as with mesothelioma patients, their families and their caregivers.
The topics that will be presented at the symposium are: Perioperative Immunotherapy; Mesothelioma Clinical Trials; Novel MRI Assessment of Mesothelioma Tumor Volume; Toxicities and Outcomes Using Whole Pleural Intensity – Modulated Proton Therapy; Understanding the Immune Response to Radiotherapy in a Dual Tumor Model of Mesothelioma; Integrative Molecular Characterization of Mesothelioma: Cancer Genome Atlas Project; A Modified Measles Virus Against Mesothelioma; An Exhaled Breath Biopsy Earmarks Exclusive Screening for MPM; Mesothelioma Immunotherapy by Controlling T Cell-Mediated Immunity; Overcoming the Immunosuppressive Tumor Microenvironment of Murine Malignant Mesothelioma and more. The event will be attended by a host of international faculty and researchers, including Kevin G. Blyth, MD, MBchB, FRCP, University of Glasgow; Nicolas Boisgerault, PhD, CRCINA Cancer Research Center, France; Lisa M. Coussens, PhD, Oregon Health and Science University, Portland; Mikihiro Kohno, MD, PhD, University of Toronto, Canada; Marc Ladanyi, MD, Memorial Sloan Kettering, New York; Kevin Lamote, PhD, University of Antwerp, Belgium; Charles B. Simone II, MD, University of Maryland Medical Center, Baltimore, Maryland; Wesley Wilson, PhD Candidate, University of Western Australia Perth, Australia, as well as local experts from UCLA. It will be hosted by Robert B. Cameron, MD, FACS, Director of the UCLA Mesothelioma Comprehensive Research Program and Professor of Thoracic Surgery at the David Geffen School of Medicine at UCLA.
Speaking of his expectations for the event, Dr. Cameron said, “There is so much exciting science from around the world in terms of treatment for mesothelioma, with promising medical advances and new research. This year we have changed the format to concentrate more on clinical and research sessions and have incredible speakers from all around the world.”
For access to information and resources on mesothelioma, contact the Patient Advocates at Mesothelioma.net at 1-800-692-8608.